DRUG · Mapped RxNorm record
Stribild
Normalized identity: StribildView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals
NCT02251236
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Genvoya
Normalized identity: GenvoyaView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedElvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIVunresolved
Interventions
StribildDRUG · verified · RxNorm: Stribild
GenvoyaDRUG · verified · RxNorm: Genvoya
Sponsors & collaborators
University of California, San Diegolead sponsor
Gilead Sciencescollaborator
University at Buffalocollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02251236 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.